Why the study?
Does implantation of early-generation sirolimus- or paclitaxel-eluting stents result in delayed neointimal growth or late catch-up phenomenon between 3 and 9 years post-PCI in patients with stable CAD?
Does implantation of early-generation sirolimus- or paclitaxel-eluting stents result in delayed neointimal growth or late catch-up phenomenon between 3 and 9 years post-PCI in patients with stable CAD?
Serial OCT assessment at 3 and 9 years post-PCI with early-generation sirolimus- and paclitaxel-eluting stents showed stable neointimal thickness and strut coverage, suggesting an absence of the 'very late catch-up' phenomenon in event-free patients.
No takes yet. Share an insight, caveat, or question.
Serial OCT up to 9 years after early-generation DES may clarify delayed healing; leaves open relevance to contemporary platforms.
Tomaniak et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: